Pharm
Imipramine
search
Imipramine
, Tofranil
See Also
Tricyclic Antidepressant
Nortriptyline
Amitriptyline
Antidepressant
SNRI
Tricyclic Antidepressant Overdose
Nocturnal Enuresis
Indications
Panic Disorder
Attention Deficit Hyperactivity Disorder
Major Depression
Nocturnal Enuresis
(not first line agent)
Background
See
Tricyclic Antidepressant
Imipramine was the prototypal, first marketed
Tricyclic Antidepressant
(first synthesized in 1951, released in 1957)
Safety
Unknown safety in pregnancy
Safe in
Lactation
Mechanism
See
Tricyclic Antidepressant
Imipramine inhibits both
Serotonin
and
Norepinephrine
reuptake
Imipramine is demethylated to
Desipramine
, which primarily inhibits
Norepinephrine
reuptake
Pharmacokinetics
Obtain serum levels in pediatric population
Avoid as full dose
Antidepressant
Serum Half Life: 11 to 25 hours
Therapeutic plasma level: 200 to 350
Dosing
Major Depression
Adults
Start: 50 to 75 mg orally at bedtime (or divided twice daily)
Titrate to 75 to 100 mg orally at bedtime (or divided twice daily)
Maximum: 150 mg mg/day
Therapeutic range 50 to 150 mg/day
Teens and Elderly
Start 30 to 40 mg orally at bedtime
Advance to 50 to 100 mg orally daily or divided twice daily as tolerated and to effect
Maximum: 100 mg/day
Dosing
Nocturnal Enuresis
in Children
Consider other measures for
Nocturnal Enuresis
first
Consider baseline EKG before starting medication
Initial dose
Avoid in age <6 years
Start at 10 mg orally nightly given one hour before bedtime
Maximum dosing: up to 0.9 to 1.5 mg/kg
Age 6-8 years
May increase dose by 10 mg every 1-2 weeks as needed up to 25-50 mg per night one hour before bed
Age 8-12 years
May increase dose by 10 mg every 1-2 weeks as needed up to 50 mg per night one hour before bed
Age over 12 years
May increase dose by 10 mg every 1-2 weeks as needed up to 75 mg per night one hour before bed
Discontinue after 3-6 months (some guidelines suggest maximum of 3 months)
Taper to one half dose nightly for 2 weeks
Taper to one half dose every other night for 2 weeks
Efficacy
Nocturnal Enuresis
Response in up to 60% of children
Relapse is common soon after stopping medication
Adverse effects
See
Tricyclic Antidepressant
s
Tricyclic Antidepressant Overdose
Significant adverse effects
Anticholinergic Symptoms
Drowsiness (but less than with
Amitriptyline
)
Sleep
problems
Gastrointestinal upset
Orthostatic Hypotension
Cardiac Arrhythmia
(
Quinidine
-like effect)
Weight gain
Precautions
See
Tricyclic Antidepressant
s
Serious cardiotoxicity in overdosage
Resources
Imipramine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa959867-4c35-4c23-8ac7-2380f3b251ec
References
(2023) Med Lett Drugs Ther 62(1592): 25-32
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 38-9
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Thiedke (2003) Am Fam Physician 67:1499-510 [PubMed]
Type your search phrase here